D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RPRX holding history
Royalty Pharma plc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 525,114
- Value
- $29.4M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 525,114 | $29.4M | <0.1% | −596,933−53.2% | Reduced | Holders |
| Q1 2026 | 1,122,047 | $53.8M | <0.1% | +283,434+33.8% | Added | Holders |
| Q4 2025 | 838,613 | $32.4M | <0.1% | +698,585+498.9% | Added | Holders |
| Q3 2025 | 140,028 | $4.94M | <0.1% | +106,232+314.3% | Added | Holders |
| Q2 2025 | 33,796 | $1.22M | <0.1% | −242,043−87.7% | Reduced | Holders |
| Q1 2025 | 275,839 | $8.59M | <0.1% | −885,465−76.2% | Reduced | Holders |
| Q4 2024 | 1,161,304 | $29.6M | <0.1% | +228,964+24.6% | Added | Holders |
| Q3 2024 | 932,340 | $26.4M | <0.1% | +898,728+2,673.8% | Added | Holders |
| Q2 2024 | 33,612 | $886.3K | <0.1% | +33,612 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −13,387−100.0% | Sold out | Holders |
| Q4 2023 | 13,387 | $376.0K | <0.1% | −384,459−96.6% | Reduced | Holders |
| Q3 2023 | 397,846 | $10.8M | <0.1% | −28,756−6.7% | Reduced | Holders |
| Q2 2023 | 426,602 | $13.1M | <0.1% | +96,782+29.3% | Added | Holders |
| Q1 2023 | 329,820 | $11.9M | <0.1% | −310,904−48.5% | Reduced | Holders |
| Q4 2022 | 640,724 | $25.3M | <0.1% | −41,062−6.0% | Reduced | Holders |
| Q3 2022 | 681,786 | $27.4M | <0.1% | +530,538+350.8% | Added | Holders |
| Q2 2022 | 151,248 | $6.36M | <0.1% | +69,947+86.0% | Added | Holders |
| Q1 2022 | 81,301 | $3.17M | <0.1% | +81,301 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −54,095−100.0% | Sold out | Holders |
| Q2 2021 | 54,095 | $2.22M | <0.1% | +54,095 | New | Holders |